IND-SWIFT LABORATORIES LTD.

NSE : INDSWFTLABBSE : 532305ISIN CODE : INE915B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE116.48-4.53 (-3.74 %)
PREV CLOSE ( ) 121.01
OPEN PRICE ( ) 122.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 47705
TODAY'S LOW / HIGH ( )115.50 124.10
52 WK LOW / HIGH ( )63.4 138.25
NSE116.55-4.3 (-3.56 %)
PREV CLOSE( ) 120.85
OPEN PRICE ( ) 122.50
BID PRICE (QTY) 116.55 (128)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 547465
TODAY'S LOW / HIGH( ) 115.10 124.00
52 WK LOW / HIGH ( )63 138.45

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.